메뉴 건너뛰기




Volumn 49, Issue 6, 2006, Pages 946-947

Peyronie's Disease: Can We Prevent Disease Progression?

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; ALPHA TOCOPHEROL; ALPHA2 INTERFERON; COLCHICINE DERIVATIVE; CORTICOSTEROID; INTERFERON ALPHA2B; TAMOXIFEN; UNCLASSIFIED DRUG; VERAPAMIL;

EID: 33646356481     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.02.048     Document Type: Editorial
Times cited : (3)

References (9)
  • 3
    • 0025609478 scopus 로고
    • The natural history of Peyronie's disease
    • Gelbard M.K., Dorey F., and James K. The natural history of Peyronie's disease. J Urol 144 (1990) 1376-1379
    • (1990) J Urol , vol.144 , pp. 1376-1379
    • Gelbard, M.K.1    Dorey, F.2    James, K.3
  • 4
    • 33646341224 scopus 로고    scopus 로고
    • A critical analysis of non-surgical treatment of Peyronie's disease
    • Hauck E.W., Diemer T., Schwelz H.U., and Weidner W. A critical analysis of non-surgical treatment of Peyronie's disease. Eur Urol 49 (2006) 987-997
    • (2006) Eur Urol , vol.49 , pp. 987-997
    • Hauck, E.W.1    Diemer, T.2    Schwelz, H.U.3    Weidner, W.4
  • 5
    • 14844339664 scopus 로고    scopus 로고
    • Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study
    • Peyronie's Disease Study Group of Andrological Group of German Urologists
    • Weidner W., Hauck E.W., Schnitker J., and Peyronie's Disease Study Group of Andrological Group of German Urologists. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study. Eur Urol 47 (2005) 530-535
    • (2005) Eur Urol , vol.47 , pp. 530-535
    • Weidner, W.1    Hauck, E.W.2    Schnitker, J.3
  • 7
    • 0036077071 scopus 로고    scopus 로고
    • Experience with intraplaque injection of verapamil for Peyronie's disease
    • Levine L.A., Goldman K.E., and Greenfield J.M. Experience with intraplaque injection of verapamil for Peyronie's disease. J Urol 168 (2002) 621-626
    • (2002) J Urol , vol.168 , pp. 621-626
    • Levine, L.A.1    Goldman, K.E.2    Greenfield, J.M.3
  • 8
    • 0032812848 scopus 로고    scopus 로고
    • A pilot study demonstrating clinical benefit from intralesional interferon alpha 2b in the treatment of Peyronie's disease
    • Ahuja S.K., Bivalacqua T.J., Case J., Vincent M., Sikka S.C., and Hellstrom W.J.G. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2b in the treatment of Peyronie's disease. J Androl 20 (1999) 444-448
    • (1999) J Androl , vol.20 , pp. 444-448
    • Ahuja, S.K.1    Bivalacqua, T.J.2    Case, J.3    Vincent, M.4    Sikka, S.C.5    Hellstrom, W.J.G.6
  • 9
    • 0033968012 scopus 로고    scopus 로고
    • Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results
    • Montorsi F., Salonia A., Guazzoni G., et al. Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results. J Androl 21 (2000) 85-90
    • (2000) J Androl , vol.21 , pp. 85-90
    • Montorsi, F.1    Salonia, A.2    Guazzoni, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.